Drug Trial Radar · NCT07298447
Donidalorsen Treatment in Children With Hereditary Angioedema
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Apr 21, 2026
Primary completion
Jun 2029
Study completion Jun 2029
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Dec 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of donidalorsen in pediatric participants with hereditary angioedema (HAE) Type I (HAE-1) or Type II (HAE-2).
Conditions
- Hereditary Angioedema (HAE)
Interventions
DonidalorsenDrug
Donidalorsen will be administered by subcutaneous (SC) injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment Emergent Adverse Events (TEAEs)Time frame: over the period of approximately 17 months
- Maximum Plasma Concentration (Cmax) of DonidalorsenTime frame: over the period of approximately 17 months
- Maximum Time to Reach Cmax (Tmax) of DonidalorsenTime frame: over the period of approximately 17 months
- Trough Plasma Concentration (Ctrough) of DonidalorsenTime frame: over the period of approximately 17 months
Locations
18 sites in 5 countries. Site status is shown where the registry gives one.
Ionis Investigative Site
Santa Monica, California · Recruiting
Ionis Investigative Site
Miami, Florida · Recruiting
Ionis Investigative Site
Baton Rouge, Louisiana · Recruiting
Ionis Investigative Site
St Louis, Missouri · Recruiting
Ionis Investigative Site
Cincinnati, Ohio · Recruiting
Ionis Investigative Site
Cleveland, Ohio · Recruiting
Ionis Investigative Site
Hershey, Pennsylvania · Recruiting
Ionis Investigative Site
West Allis, Wisconsin · Recruiting
Ionis Investigative Site
Murdoch, Australia · Recruiting
Ionis Investigative Site
South Brisbane, Queensland, Australia · Recruiting
Ionis Investigative Site
Clayton, Victoria, Australia · Recruiting
Ionis Investigative Site
Milan, Italy · Recruiting
Ionis Investigative Site
Padova, Italy · Recruiting
Ionis Investigative Site
Roma, Italy · Recruiting
Ionis Investigative Site
San Donato Milanese, Italy · Recruiting
Ionis Investigative Site
Krakow, Poland · Recruiting
Ionis Investigative Site
Warsaw, Poland · Recruiting
Ionis Investigative Site
Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.